Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients: 3 Years Follow-Up of the ZEUS Trial

被引：0
|
作者：
Budde, K. [1 ]
Arns, W. [1 ]
Sommerer, C. [1 ]
Reinke, P. [1 ]
Eisenberger, U. [1 ]
Vogel, E. -M. [2 ]
Kramer, S. [2 ]
Witzke, O. [1 ]
Becker, T. [1 ]
机构：
[1] ZEUS Study Grp, Nurnberg, Germany
[2] Novartis Pharmaceut, Nurnberg, Germany
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2011年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
116
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [41] AN INTENSIFIED DOSING OF ENTERIC-COATED MYCOPHENOLATE SODIUM IN RENAL TRANSPLANT PATIENTS RESULTS IN IMPROVED EFFICACY WITHOUT COMPROMISING SAFETY
    Sommerer, C.
    Arns, W.
    Zeier, M.
    Ariatabar, T.
    Glander, P.
    Vogel, E. -M.
    Budde, K.
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 67 - 67
  • [42] Renal function with enteric-coated mycophenolate sodium in combination with reduced and standard tacrolimus levels: Results of a 6-month comparative study in de novo renal transplant recipients
    Hart, Marquis
    Chan, Laurence
    Andres, Amado
    Bloom, Roy
    Bunnapradist, Suphamai
    Kaplan, Bruce
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 583 - 583
  • [43] Renal Function of an Everolimus Based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients: 3 Year Data of the APOLLO Trial.
    Budde, K.
    Sommerer, C.
    Haller, H.
    Suwelack, B.
    May, C.
    Paulus, E. -M.
    Witzke, O.
    Reinke, P.
    Rath, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 298 - 298
  • [44] Use of enteric-coated mycophenolate sodium in de novo renal transplant recipients with high incidence of delayed graft function (vol 38, pg 905, 2006)
    Schlavelli, R.
    Gaite, L.
    Carreno, C. Agost
    Baran, M.
    Novoa, P.
    Massari, P.
    Otero, A. B.
    Piulats, E.
    [J]. TRANSPLANTATION PROCEEDINGS, 2006, 38 (05) : 1641 - 1641
  • [45] Improvement of Renal Graft Function After Conversion From a Calcineurin Inhibitor Including Immunosuppression to a Mycophenolate Sodium Including Regimen: A 4-year Follow-up
    Heeg, M. H. J.
    Mueller, G. A.
    Bramlage, C.
    Homayounfar, K.
    Muehlhausen, J.
    Leha, A.
    Koziolek, M. J.
    [J]. TRANSPLANTATION PROCEEDINGS, 2013, 45 (01) : 142 - 147
  • [46] TWO YEAR DATA OF THE APOLLO TRIAL: RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS
    Reinke, P.
    Haller, H.
    Rath, T.
    Arns, W.
    Paulus, E. -M.
    Scheidl, S.
    Witzke, O.
    Sommerer, C.
    Budde, K.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 50 - 50
  • [47] Efficacy and safety of enteric-coated mycophenolate sodium, cyclosporiine and steroids in De novo pediatric renal transplant patients:: 12-months results of a multicenter study
    Niaudet, Patrick
    Loirat, Chantal
    Tsimaratos, Michel
    Dehennault, Maud
    Quere, Stephane
    Lemay, Djamila
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 372 - 372
  • [48] Renal function with delayed or immediate cyclosporine microemulsion in combination with enteric-coated mycophenolate sodium and steroids:: results of follow up to 30 months post-transplant
    Mourad, Georges
    Karras, Alexandre
    Kamar, Nassim
    Garrigue, Valerie
    Legendre, Christophe
    Lefrancois, Nicole
    Charpentier, Bernard
    Bourbigot, Bernard
    Pouteil-Noble, Claire
    Bayle, Francos
    Lebranchu, Yvon
    Mariat, Christophe
    Le Meur, Yann
    Kessler, Michele
    Moulin, Bruno
    Ducloux, Didier
    Delahousse, Michel
    Lang, Philippe
    Merville, Pierre
    Chaouche-Teyara, Kamel
    Rostaing, Lionel
    [J]. CLINICAL TRANSPLANTATION, 2007, 21 (03) : 295 - 300
  • [49] Rationale, design and statistical analysis of a prospective randomized trial comparing initially intensified vs standard dose regimens of enteric-coated mycophenolate sodium in De novo renal transplant patients
    Budde, Klemens
    Arns, Wolfgang
    Grandaliano, Giuseppe
    Kiberd, Bryce
    Kuypers, Dirk
    Walker, Rowan
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 208 - 208
  • [50] Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab:: a 12-month randomized trial in renal transplant recipients
    Cibrik, Diane
    Meier-Kriesche, Herwig-Ulf
    Bresnahan, Barbara
    Wu, You Min
    Klintmalm, Goran
    Kew, Clifton E.
    Kuo, Paul C.
    Whelchel, John
    Cohen, David
    Baliga, Prabakar
    Akalin, Enver
    Benedetti, Enrico
    Wright, Francis
    Lieberman, Bonnie
    Ulbricht, Bettina
    Jensik, Stephen
    [J]. CLINICAL TRANSPLANTATION, 2007, 21 (02) : 192 - 201
12345